Yes - all the evidence reported to date has been pretty...

Yes - all the evidence reported to date has been pretty compelling .

I reckon there's going to be lots and lots of interest in what HXL are doing with this new class of antifungal remedy

The stock is quite thinly traded and well off its recent highs ( like so m any other biotecs at the moment . )
Its hard to get set in any volume , similarly hard to unload any volume . That may all change of course as confidence grows .

Meanwhile the need for the product keeps growing .........

Looking forward also to more news on potential applications as well .